|
Market Closed –
|
5-day change | 1st Jan Change | ||
|
217.22 USD |
+0.27% | -1.02% | -33.69% | |
Published on 05/19/2025 at 21:41
Presenter Speech
Michael Ryskin (Analysts)
My name is Mike Ryskin. I’m on the Bank of America Life Science Tools and Diagnostics team here at Bank of America.
For our next
|
West Pharmaceutical Services, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 02:20 PM |
09:41pm |
|
|
Jefferies & Co Adjusts West Pharmaceutical Services Price Target to $245 From $240, Maintains Buy Rating |
Apr. 25 |
MT |
|
Tranche Update on West Pharmaceutical Services, Inc.’s Equity Buyback Plan announced on February 16, 2023. |
Apr. 24 |
CI |
|
Tranche Update on West Pharmaceutical Services, Inc.’s Equity Buyback Plan announced on December 13, 2024. |
Apr. 24 |
CI |
|
West Pharmaceutical CFO Bernard Birkett to Retire |
Apr. 24 |
MT |
|
West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Second Quarter of the Year 2025 |
Apr. 24 |
CI |
|
West Pharmaceutical Services, Inc., Q1 2025 Earnings Call, Apr 24, 2025 |
Apr. 24 |
|
|
West Pharmaceutical Services Bernard Birkett To Retire As CFO Of Co Later This Year |
Apr. 24 |
RE |
|
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Uncertain Trade Policies, Mixed Earnings |
Apr. 24 |
MT |
|
Bernard Birkett to Retire as Chief Financial Officer of West Pharmaceutical Services, Inc. Later 2025 |
Apr. 24 |
CI |
|
West Pharmaceutical Services, Inc. Announces Management Changes |
Apr. 24 |
CI |
|
West Pharma raises profit forecast as dollar weakens amid Trump’s tariff policies |
Apr. 24 |
RE |
|
(WST) West Pharmaceutical Services Expects Full Year 2025 Net Sales Range $2.95B – $2.98B, vs. FactSet Est of $2.90B |
Apr. 24 |
MT |
|
(WST) West Pharmaceutical Services Expects Full Year 2025 Adjusted EPS Range $6.15 – $6.35, vs. FactSet Est of $6.11 |
Apr. 24 |
MT |
|
West Announces Leadership Changes |
Apr. 24 |
RE |
|
Earnings Flash (WST) West Pharmaceutical Services Posts Q1 Revenue $698M, vs. FactSet Est of $685.7M |
Apr. 24 |
MT |
|
Earnings Flash (WST) West Pharmaceutical Services Reports Q1 Adjusted EPS $1.45, vs. FactSet Est of $1.23 |
Apr. 24 |
MT |
|
West Pharmaceutical Services, Inc. Raises Earnings Guidance for the Full Year 2025 |
Apr. 24 |
CI |
|
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 |
Apr. 24 |
CI |
|
BofA Securities Cuts West Pharmaceutical Services Price Target to $280 From $285, Maintains Neutral Rating |
Apr. 14 |
MT |
|
Trump administration shutters DC foreign policy think tank Wilson Center |
Apr. 03 |
RE |
|
West Pharmaceutical Services, Inc. Presents at KeyBanc Annual Healthcare Forum 2025, Mar-19-2025 01:30 PM |
Mar. 19 |
|
|
Evercore ISI Initiates West Pharmaceutical Services at Outperform With $275 Price Target |
Mar. 18 |
MT |
|
West Pharmaceutical Services, Inc. Presents at Barclays 27th Annual Global Healthcare Conference 2025, Mar-12-2025 11:00 AM |
Mar. 12 |
|
|
West Pharmaceutical Services, Inc. Announces Executive Changes |
Mar. 11 |
CI |
WST: Dynamic Chart
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
